Clinical Trials Week

Finance - Pharmaceutical company announces revenues of $1M due to Plenaxis sales

Finance - Pharmaceutical company reports loss of $0.16 per share

Finance - Pharmaceutical company reports third quarter results

Finance - Zyflo maker reports $6.6 million net loss for Q3, provides clinical update

Gastric Ulcer - Biopharma company initiates phase II trial with TB4 for chronic pressure ulcers

Gastric Ulcer - Study finds new treatment option for moderately active ulcerative colitis

Gastroesophageal Reflux Disease - Clinical trial results of nocturnal gastric acidity drugs comparison reported

Graft-versus-Host Disease - Cyclosporin and MMF for GVHD prophylaxis associated with faster engraftment

HIV/AIDS - New information on TRIZIVIR presented at conference

HIV/AIDS - Phase II data for HIV drug presented at conference

HIV/AIDS - Phase IIa study show Reverset potentially reduces HIV viral load

Hepatitis - PEGASYS provides lasting remission compared to lamivudine

Hepatitis - Trial results for spi-VECTM oral immunotherapeutic vaccine reported

Hepatitis B - European authorities give positive opinion for Fendrix vaccine

Hepatitis B Virus - Phase II trial data announced on new HBV vaccine

Hepatitis B Virus - Trials show hepatitis B agent a statistical improvement in infected patients

Hepatitis C Therapy - Hepatitis C viral load reduction reported in phase IB trial of isatoribine

Hepatitis C Virus - Peginterferon alfa-2B studies show positive data in treatment of hepatitis C

Herpesvirus - Pre-IND contact initiated with U.S. FDA for clinical trials of CY301 for herpes

Immunosuppressive drugs - Study results announced for immunosuppressive drug

Influenza Vaccine - Enrollment complete for intranasal influenza vaccine trial

Informed Consent - Communication in the early era of gene transfer trials was unclear

Invasive Fungal Infections - Data on drug for treating invasive fungal infection in at-risk patients reported

Irritable Bowel Syndrome - Data show cilansetron improves quality of life in patients with IBS-D

Kidney Disease - Pharmaceutical company presents results from clinical trials of lupus treatment

Mergers & Acquisitions - Drug development company to merge with PharmaNet, Inc.

Multiple Myeloma - FDA issues approvable letter for Thalomid sNDA

Neurology - BrainGate Neural Interface translates neural activity into computer control

Oncology - Study results show anti-tumor activity

Organ Transplant - NDA submitted immunosuppressant for chronic lung-transplant rejection

Ovarian Cancer - Controversies over treatments reviewed

Pain Therapy - Company launches phase II clinical program for postoperative pain relief

Paroxysmal Nocturnal Hemoglobinuria - Treatment initiated in phase III Eculizumab study

Personnel - Central laboratory services provider appoints VP business development

Personnel - Clinical trials company names executive VP and chief financial officer

Personnel - Global research organization appoints head of Latin American expansion

Personnel - Global research organization appoints medical device consultant

Pneumonia - Avelox study reports faster symptom relief, earlier hospital discharge

Prognostics - Clinical data shows eTag's potential in predicting response to cancer treatment

Prostate Cancer - Company to initiate phase II study with Quinamed in prostate cancer

Prostate Cancer - Pharma companies awarded NIH grants for prostate cancer immunotherapies

Respiratory Infections - Studies show single-dose azithromycin as effective as multi-dose for infections

Synthetic Blood - Red blood cell substitute in trials with Virginia Commonwealth for U.S. Navy

Thyroid Cancer - Company seeks new therapeutic indication for Thyrogen

Ulcerative Colitis - New treatment option offered for patients with moderate ulcerative colitis

Urethritis - Positive phase II results reported on Rifalazil

Vaccine Development - Company says skin immunization may expand flu vaccine supply